Is There a Relationship between the Stratum Corneum Thickness and That of the Viable Parts of Tumour Cells in Basal Cell Carcinoma?

about

Is There a Relationship between the Stratum Corneum Thickness and That of the Viable Parts of Tumour Cells in Basal Cell Carcinoma?

Item

http://www.wikidata.org/entity/Q38363378

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Is There a Relationship betwee ...... Cells in Basal Cell Carcinoma?

@en

type

Item

label

Is There a Relationship betwee ...... Cells in Basal Cell Carcinoma?

@en

prefLabel

Is There a Relationship betwee ...... Cells in Basal Cell Carcinoma?

@en

P1476

Is There a Relationship betwee ...... Cells in Basal Cell Carcinoma?

@en

P2093

Eidi Christensen

http://www.w3.org/2001/XMLSchema#string

Olav A Foss

http://www.w3.org/2001/XMLSchema#string

Patricia Mjønes

http://www.w3.org/2001/XMLSchema#string

Silje Fismen

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for basal cell carcinoma of the skin

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters.

Drug delivery across the skin.

Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.

Basal cell carcinoma: biology, morphology and clinical implications.

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Guidelines for practical use of MAL-PDT in non-melanoma skin cancer.

European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.

Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.

P304

6146091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/6146091

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292205870

http://www.w3.org/2001/XMLSchema#string

P698

26942011

http://www.w3.org/2001/XMLSchema#string

P932

4749825

http://www.w3.org/2001/XMLSchema#string